Acquired elliptocytosis as presenting sign of a myelodysplastic syndrome associated with deletion of chromosome 20 and mutations in TET2, DNMT3A, and U2AF1

Ann Hematol. 2021 Aug;100(8):2111-2112. doi: 10.1007/s00277-020-04368-w. Epub 2021 Jan 6.

Christoph Robier^{1

2}, Gerald Hoefler³, Kristina Aubell⁴, Eva Hubmann⁵

¹ Institute of Laboratory Diagnostics, Hospital of the Brothers of St. John of God, Marschallgasse 12, Graz, A-8020, Austria. [email protected].
² Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria. [email protected].
³ Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
⁴ Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.
⁵ Department of Internal Medicine 1, Hospital of the Brothers of St. John of God, Graz, Austria.

No abstract available

Publication types